Non-Hodgkin Lymphoma
Seattle Genetics Reports Preclinical Data on SGN-40 and an Anti-CD19 Antibody-Drug Conjugate
Published in Blood Weekly, November 8th, 2007
Seattle Genetics, Inc. (Nasdaq: SGEN) reported preclinical data on SGN-40, a humanized monoclonal antibody that is currently in clinical trials for non-Hodgkin's lymphoma and multiple myeloma in collaboration with Genentech, Inc. In addition, data were presented by Seattle Genetics on its proprietary anti-CD19 antibody-drug conjugate (ADC) for the treatment of a variety of hematologic malignancies, and several of the company's collaborators presented on their own ADC programs.
The data are being presented at the American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer (AACR-NCI-EORTC) International...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-11-08)
More Articles from Blood Weekly
- Hepatocellular Cancer
A new chemotherapeutic target for hepatocellular carcinoma - Blood Safety
Blood Donations in U.S. Testing Positive for Chagas' Disease - Endotoxemia
Research results from University of Crete, Medical Department update understanding of endotoxemia - Gaucher Disease
Research from National Institutes of Health provide new insights into Gaucher disease - HIV/AIDS
First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs - HIV/AIDS
Study data from S.K. Lau and co-authors update knowledge of HIV/AIDS - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
